QT
SGMO

Quantamental Technologies’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Quantamental Technologies’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,456
Closed -$108K – 247
2020
Q3 		$108K Buy
+11,456
New +$124K 0.08% 240
2020
Q1 		– Sell
-12,656
Closed -$106K – 354
2019
Q4 		$106K Buy
+12,656
New +$116K 0.05% 406
2019
Q1 		– Sell
-872
Closed -$10K – 1751
2018
Q4 		$10K Buy
+872
New +$10.8K 0.01% 1146

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantamental Technologies's SGMO Position: Q4 2020 in Review

Quantamental Technologies sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2020, closing a stake of 11,456 shares — an estimated $108K sold.

Quantamental Technologies first reported a position in SGMO in Q4 2018 and held it in 3 quarters. The position peaked at $108K in Q3 2020. 223 funds tracked by Wall St. Rank hold SGMO as of Q4 2020.

  • Quantamental Technologies reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2020 after selling out during the quarter.
  • Quantamental Technologies sold 11,456 SANGAMO THERAPEUTICS INC shares in Q4 2020, an estimated $108K.
  • Quantamental Technologies first reported a position in SANGAMO THERAPEUTICS INC in Q4 2018 and held it in 3 quarters.
  • Quantamental Technologies's SANGAMO THERAPEUTICS INC position peaked at $108K in Q3 2020.
  • 223 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2020.

Based on Quantamental Technologies's 13F filing for Q4 2020, filed 16 Feb 2021.